Primary |
Drug Use For Unknown Indication |
29.9% |
Anxiety |
17.7% |
Product Used For Unknown Indication |
13.8% |
Insomnia |
6.3% |
Depression |
5.0% |
Agitation |
3.9% |
Sedation |
2.8% |
Convulsion |
2.1% |
Panic Attack |
2.1% |
Sleep Disorder |
1.8% |
Bipolar Disorder |
1.6% |
Drug Withdrawal Syndrome |
1.6% |
Generalised Anxiety Disorder |
1.6% |
Schizophrenia |
1.6% |
Hypertension |
1.5% |
Immunisation |
1.5% |
Premedication |
1.5% |
Pain |
1.3% |
Stress |
1.3% |
Dementia Alzheimer's Type |
1.1% |
|
Somnolence |
8.4% |
Suicidal Ideation |
7.8% |
Tremor |
7.1% |
Weight Decreased |
7.1% |
Withdrawal Syndrome |
7.1% |
Pharmaceutical Product Complaint |
6.5% |
Death |
5.8% |
Therapeutic Response Unexpected With Drug Substitution |
5.2% |
Vomiting |
5.2% |
Drug Dependence |
4.5% |
Overdose |
4.5% |
Product Substitution Issue |
4.5% |
Respiratory Failure |
3.9% |
Unresponsive To Stimuli |
3.9% |
Drug Toxicity |
3.2% |
Loss Of Consciousness |
3.2% |
Nausea |
3.2% |
Respiratory Arrest |
3.2% |
Drug Ineffective |
2.6% |
Drug Withdrawal Syndrome |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
21.8% |
Drug Use For Unknown Indication |
14.3% |
Anxiety |
9.6% |
Pain |
7.7% |
Depression |
7.4% |
Agitation |
5.5% |
Convulsion |
5.4% |
Insomnia |
5.1% |
Nausea |
2.7% |
Back Pain |
2.4% |
Bipolar Disorder |
2.1% |
Prophylaxis |
2.1% |
Crohn's Disease |
2.0% |
Hypertension |
1.8% |
Schizophrenia |
1.8% |
Thrombosis Prophylaxis |
1.7% |
Constipation |
1.7% |
Psychotic Disorder |
1.7% |
Chest Pain |
1.6% |
Sedation |
1.6% |
|
Suicide Attempt |
11.0% |
Somnolence |
9.1% |
Drug Hypersensitivity |
7.9% |
Tremor |
7.9% |
Vomiting |
6.3% |
Weight Decreased |
6.3% |
Withdrawal Syndrome |
6.3% |
Suicidal Ideation |
5.4% |
Weight Increased |
5.0% |
Ventricular Extrasystoles |
4.7% |
Overdose |
4.1% |
Emphysema |
3.2% |
Fall |
3.2% |
Nausea |
3.2% |
Mental Status Changes |
2.8% |
Psychotic Disorder |
2.8% |
Tachycardia |
2.8% |
Treatment Noncompliance |
2.8% |
Amnesia |
2.5% |
Convulsion |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
25.9% |
Drug Use For Unknown Indication |
16.3% |
Anxiety |
8.7% |
Pain |
6.9% |
Depression |
6.5% |
Hypertension |
4.4% |
Nausea |
4.0% |
Multiple Myeloma |
3.4% |
Insomnia |
3.0% |
Prophylaxis |
2.6% |
Bipolar Disorder |
2.4% |
Sleep Disorder |
2.2% |
Breast Cancer |
2.1% |
Gastrooesophageal Reflux Disease |
2.0% |
Non-small Cell Lung Cancer |
1.9% |
Schizophrenia |
1.8% |
Crohn's Disease |
1.7% |
Constipation |
1.6% |
Osteoporosis |
1.4% |
Agitation |
1.2% |
|
Vomiting |
15.2% |
Weight Decreased |
10.6% |
Weight Increased |
8.9% |
Type 2 Diabetes Mellitus |
7.5% |
Nausea |
4.8% |
Death |
4.7% |
Urinary Tract Infection |
4.3% |
Pneumonia |
4.2% |
Tremor |
4.1% |
White Blood Cell Count Decreased |
3.9% |
Pulmonary Embolism |
3.8% |
Suicidal Ideation |
3.7% |
Vision Blurred |
3.7% |
Pain |
3.4% |
Drug Ineffective |
3.4% |
White Blood Cell Count Increased |
3.1% |
Rash |
3.0% |
Pyrexia |
2.8% |
Thrombocytopenia |
2.7% |
Dyspnoea |
2.4% |
|
Interacting |
Product Used For Unknown Indication |
23.7% |
Drug Use For Unknown Indication |
10.2% |
Dementia With Lewy Bodies |
9.3% |
Depression |
7.4% |
Smoking Cessation Therapy |
7.4% |
Insomnia |
6.5% |
Anxiety |
6.0% |
Pain |
5.6% |
Bipolar Disorder |
3.7% |
Ill-defined Disorder |
2.3% |
Sleep Disorder |
2.3% |
Analgesic Therapy |
1.9% |
Catatonia |
1.9% |
Fibromyalgia |
1.9% |
Mania |
1.9% |
Neuralgia |
1.9% |
Post-traumatic Stress Disorder |
1.9% |
Back Pain |
1.4% |
Oesophagitis |
1.4% |
Paraesthesia |
1.4% |
|
Weight Increased |
20.5% |
Drug Interaction |
18.2% |
Abnormal Behaviour |
6.8% |
Somnolence |
6.8% |
Anxiety |
4.5% |
Hypersomnia |
4.5% |
Surgery |
4.5% |
Unevaluable Event |
4.5% |
Weight Decreased |
4.5% |
Agranulocytosis |
2.3% |
Amnesia |
2.3% |
Balance Disorder |
2.3% |
Confusional State |
2.3% |
Dementia With Lewy Bodies |
2.3% |
Drug Screen False Positive |
2.3% |
Fall |
2.3% |
Feeling Abnormal |
2.3% |
Loss Of Consciousness |
2.3% |
Middle Insomnia |
2.3% |
Musculoskeletal Stiffness |
2.3% |
|